0001144204-11-064443.txt : 20111114 0001144204-11-064443.hdr.sgml : 20111111 20111114164224 ACCESSION NUMBER: 0001144204-11-064443 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110930 FILED AS OF DATE: 20111114 DATE AS OF CHANGE: 20111114 EFFECTIVENESS DATE: 20111114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RA CAPITAL MANAGEMENT, LLC CENTRAL INDEX KEY: 0001346824 IRS NUMBER: 830406777 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-12884 FILM NUMBER: 111203479 BUSINESS ADDRESS: STREET 1: 20 PARK PLAZA, SUITE 905 CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-778-2500 MAIL ADDRESS: STREET 1: 20 PARK PLAZA, SUITE 905 CITY: BOSTON STATE: MA ZIP: 02116 13F-HR 1 v240249_13fhr.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F FORM 13F COVER PAGE Report for the Calendar Year or Quarter Ended: September 30, 2011 Check here if Amendment [ ]; Amendment Number: ---------- This Amendment (Check only one): [ ] is a restatement. [ ] adds new entries. Institutional Investment Manager Filing this Report: Name: RA Capital Management, LLC ------------------------------------------------------------------- Address: 20 Park Plaza, Suite 1200 ------------------------------------------------------------------- Boston, MA 02116 ------------------------------------------------------------------- ------------------------------------------------------------------- ------------------------------------------------------------------- Form 13F File Number: 28-12884 ------------------------- The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Peter Kolchinsky ------------------------------------------ Title: Manager ------------------------------------------ Phone: (617) 778-2500 ------------------------------------------ Signature, Place, and Date of Signing /s/ Peter Kolchinsky Boston, MA November 14, 2011 ------------------------------ ----------------------- ------------------- [Signature] [City, State] [Date] Report Type (Check only one): [X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [ ] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) List of Other Managers Reporting for this Manager: NONE FORM 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 0 ---------------------- Form 13F Information Tabel Entry Total: 28 ---------------------- Form 13F Information Table Value Total: 114,169 ---------------------- (thousands) List of Other Included Managers: NONE FORM 13F INFORMATION TABLE
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8 -------- -------- -------- -------- -------- -------- -------- -------- VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGERS SOLE / SHARED / NONE ------------------------------------------------------------------------------------------------------------------------------------ ACADIA PHARMACEUTICALS INC COM 004225 10 8 5,692 5,269,999 SH SOLE N/A 5,269,999 ------------------------------------------------------------------------------------------------------------------------------------ ALEXZA PHARMACEUTICALS INC COM 015384 10 0 4,218 3,905,653 SH SOLE N/A 3,905,653 ------------------------------------------------------------------------------------------------------------------------------------ ANACOR PHARMACEUTICALS INC COM 032420 10 1 2,634 462,100 SH SOLE N/A 462,100 ------------------------------------------------------------------------------------------------------------------------------------ ANTHERA PHARMACEUTICALS INC COM 03674U 10 2 1,759 368,807 SH SOLE N/A 368,807 ------------------------------------------------------------------------------------------------------------------------------------ ARTHROCARE CORP COM 043136 10 0 7,329 254,749 SH SOLE N/A 254,749 ------------------------------------------------------------------------------------------------------------------------------------ CARDIONET INC COM 14159L 10 3 4,007 1,335,582 SH SOLE N/A 1,335,582 ------------------------------------------------------------------------------------------------------------------------------------ COLUMBIA LABS INC COM 197779 10 1 8,145 4,177,159 SH SOLE N/A 4,177,159 ------------------------------------------------------------------------------------------------------------------------------------ DERMA SCIENCES INC COM PAR $.01 249827 50 2 6,202 796,212 SH SOLE N/A 796,212 ------------------------------------------------------------------------------------------------------------------------------------ DISCOVERY LABORATORIES INC N COM NEW 254668 40 3 256 130,497 SH SOLE N/A 130,497 ------------------------------------------------------------------------------------------------------------------------------------ ENDOCYTE INC COM 29269A 10 2 4,170 393,354 SH SOLE N/A 393,354 ------------------------------------------------------------------------------------------------------------------------------------ ENZO BIOCHEM INC COM 294100 10 2 3,556 1,383,830 SH SOLE N/A 1,383,830 ------------------------------------------------------------------------------------------------------------------------------------ FURIEX PHARMACEUTICALS INC COM 36106P 10 1 2,079 146,101 SH SOLE N/A 146,101 ------------------------------------------------------------------------------------------------------------------------------------ GENTIUM S P A SPONSORED ADR 37250B 10 4 3,727 611,023 SH SOLE N/A 611,023 ------------------------------------------------------------------------------------------------------------------------------------ INHIBITEX INC COM 45719T 10 3 4,835 1,965,405 SH SOLE N/A 1,965,405 ------------------------------------------------------------------------------------------------------------------------------------ ONCOGENEX PHARMACEUTICALS IN COM 68230A 10 6 7,550 770,431 SH SOLE N/A 770,431 ------------------------------------------------------------------------------------------------------------------------------------ PHARMASSET INC COM 71715N 10 6 5,733 69,600 SH SOLE N/A 69,600 ------------------------------------------------------------------------------------------------------------------------------------ RAPTOR PHARMACEUTICAL CORP COM 75382F 10 6 4,059 900,000 SH SOLE N/A 900,000 ------------------------------------------------------------------------------------------------------------------------------------ SEQUENOM INC COM NEW 817337 40 5 13,449 2,637,067 SH SOLE N/A 2,637,067 ------------------------------------------------------------------------------------------------------------------------------------ SUNESIS PHARMACEUTICALS INC COM NEW 867328 60 1 510 414,793 SH SOLE N/A 414,793 ------------------------------------------------------------------------------------------------------------------------------------ SYNTA PHARMACEUTICALS CORP COM 87162T 20 6 1,512 465,284 SH SOLE N/A 465,284 ------------------------------------------------------------------------------------------------------------------------------------ TARGACEPT INC COM 87611R 30 6 1,410 93,987 SH SOLE N/A 93,987 ------------------------------------------------------------------------------------------------------------------------------------ TARGACEPT INC COM 87611R 30 6 305 20,300 SH CALL SOLE N/A ------------------------------------------------------------------------------------------------------------------------------------ TEARLAB CORP COM 878193 10 1 1,245 1,383,700 SH SOLE N/A 1,383,700 ------------------------------------------------------------------------------------------------------------------------------------ TENGION INC COM 88034G 10 9 572 1,060,070 SH SOLE N/A 1,060,070 ------------------------------------------------------------------------------------------------------------------------------------ TRIMERIS INC COM 896263 10 0 3,929 1,559,106 SH SOLE N/A 1,559,106 ------------------------------------------------------------------------------------------------------------------------------------ UROPLASTY INC COM NEW 917277 20 4 1,799 371,014 SH SOLE N/A 371,014 ------------------------------------------------------------------------------------------------------------------------------------ VANDA PHARMACEUTICALS INC COM 921659 10 8 7,115 1,437,320 SH SOLE N/A 1,437,320 ------------------------------------------------------------------------------------------------------------------------------------ VENTRUS BIOSCIENCES INC COM 922822 10 1 6,370 705,450 SH SOLE N/A 705,450 ------------------------------------------------------------------------------------------------------------------------------------